Galderma Group AG
GALD
株式のランク
#459
Galderma Group AG operates as a dermatology company worldwide. The company... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
株価
$224.81
時価総額
$52.42B
変化（1日）
6.31%
変化（1年）
31.28%
国
CH
取引 Galderma Group AG (GALD)
カテゴリー
Healthcare
Galderma Group AG（GALD）のP/S比率
October 2026 時点のP/S比率 TTM: 8.92
Galderma Group AG の最新の財務報告および株価によると、現在のP/S比率（TTM）は 8.92 です。2024 年末時点でのP/S比率は 5.38 でした。
Galderma Group AG の P/S 比率の履歴（2021 ～ 2026）
各年末時点のP/S比率
| 年 | P/S比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 8.92 | -3.45% |
| 2025 | 9.24 | 71.63% |
| 2024 | 5.38 | 56.84% |
| 2023 | 3.43 | -2.09% |
| 2022 | 3.51 | -13.02% |
| 2021 | 4.03 | 0.00% |
同業他社のP/S比率
| 企業 | P/S比率 | P/S比率の差 | 国 |
|---|---|---|---|
| 2.82 | -68.43% |
DE
|
|
| 3.02 | -66.17% |
DE
|
|
| 2.19 | -75.49% |
JP
|
|
| 7.04 | -21.08% |
IN
|
|
| 9.37 | 5.01% |
CN
|
